Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05612750
Other study ID # IRB-65439
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date May 1, 2028

Study information

Verified date April 2023
Source Stanford University
Contact Emma A Adair, BS
Phone 6097448937
Email eadair@stanford.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to conduct a pragmatic clinical trial comparing the effectiveness of: (1) 8-week cognitive behavioral therapy for chronic pain (pain-CBT; sixteen hours total treatment time); and (2) a 1-session pain relief skills intervention for chronic pain (Empowered Relief; two hours total treatment time).


Description:

The purpose of this study is to conduct a pragmatic clinical trial comparing the effectiveness: (1) 8-session cognitive behavioral therapy for chronic pain (pain-CBT); and (2) a 1-session pain relief skills intervention for chronic pain (Empowered Relief). The investigators aim to understand for patients which treatment works best. Online evidence-based behavioral treatment for pain will greatly expand access to patients across the U.S. living with diverse chronic pain conditions. Results from this study will fill several critical gaps in evidence that are preventing patients and physicians from making informed decisions about their pain care. This study will provide a low-cost, relatively low-risk, widely available and feasible protocol that directly addresses the needs of millions of community-based outpatients and their physicians.


Recruitment information / eligibility

Status Recruiting
Enrollment 1200
Est. completion date May 1, 2028
Est. primary completion date May 1, 2028
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. At least 18 years of age or older of either sex (and all genders). 2. Chronic pain (pain that occurs on at least half of the days of 3 months or more). 3. Past-month average pain intensity score of at least 3/10. 4. Ability to adhere to and complete study protocols. Exclusion Criteria: 1. Inability to provide informed consent. 2. Cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material and/or full participation in the study including group treatment. 3. Active suicidality at screening. 4. Study staff may exclude individuals with a known history of disruptive behavior to minimize contamination of the learning environment for an entire treatment cohort. 5. Receipt of either study treatment in the past 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Education
Participants will receive one of two educational programs.

Locations

Country Name City State
United States Lehigh Valley Health Network Allentown Pennsylvania
United States SCAN Health Plan Long Beach California
United States Humana Louisville Kentucky
United States Phoenix VA Health Care System Phoenix Arizona
United States Intermountain Healthcare Salt Lake City Utah

Sponsors (2)

Lead Sponsor Collaborator
Stanford University Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Exploratory Outcome Health Service Utilization We will utilize EMR and database records to compare treatment groups for healthcare utilization (e.g., medical visits) during final 3 months of the study vs. 3 months prior to enrollment. 6 months
Primary Pain Intensity Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10) 1 months
Primary Pain Intensity Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10) 2 months
Primary Pain Intensity Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10) 3 months
Primary Pain Intensity Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10) 6 months
Primary Pain Interference Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10) 1 month
Primary Pain Interference Compare study treatments for primary outcomes post-treatment with the PROMIS Pain Interference 6-item scale. 2 months
Primary Pain Interference Compare study treatments for primary outcomes post-treatment with the PROMIS Pain Interference 6-item scale. 3 months
Primary Pain Interference Compare study treatments for primary outcomes post-treatment with the PROMIS Pain Interference 6-item scale. 6 months
Secondary Sleep Disturbance Compare treatment groups on the PROMIS Sleep Disturbance 6-item 1 month
Secondary Sleep Disturbance Compare treatment groups on the PROMIS Sleep Disturbance 6-item 2 months
Secondary Sleep Disturbance Compare treatment groups on the PROMIS Sleep Disturbance 6-item 3 months
Secondary Sleep Disturbance Compare treatment groups on the PROMIS Sleep Disturbance 6-item 6 months
Secondary Pain Bothersomeness Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10) 1 month
Secondary Pain Bothersomeness Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10) 2 months
Secondary Pain Bothersomeness Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10) 3 months
Secondary Pain Bothersomeness Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10) 6 months
Secondary Pain Catastrophizing Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing. 1 months
Secondary Pain Catastrophizing Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing. 2 months
Secondary Pain Catastrophizing Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing. We aim to obtain >30% reduction in PCS scores after the intervention 3 months
Secondary Pain Catastrophizing Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing. 6 months
Secondary Anxiety Compare treatment groups for anxiety using the PROMIS Anxiety 6-item 1 month
Secondary Anxiety Compare treatment groups for anxiety using the PROMIS Anxiety 6-item 2 months
Secondary Anxiety Compare treatment groups for anxiety using the PROMIS Anxiety 6-item 3 months
Secondary Anxiety Compare treatment groups for anxiety using the PROMIS Anxiety 6-item 6 months
Secondary Satisfaction with Social Roles/Responsibilities Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities 1 month
Secondary Satisfaction with Social Roles/Responsibilities Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities 2 months
Secondary Satisfaction with Social Roles/Responsibilities Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities 3 months
Secondary Satisfaction with Social Roles/Responsibilities Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities 6 months
Secondary Patient Global Impression of Change Compare treatment groups for PROMISE 1 item Global Impression of Change scale 1months
Secondary Patient Global Impression of Change Compare treatment groups for PROMISE 1 item Global Impression of Change scale 2 month
Secondary Patient Global Impression of Change Compare treatment groups for PROMISE 1 item Global Impression of Change scale 3 months
Secondary Patient Global Impression of Change Compare treatment groups for PROMISE 1 item Global Impression of Change scale 6 months
Secondary Depression Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale. 1 month
Secondary Depression Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale. 2 months
Secondary Depression Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale. 3 months
Secondary Depression Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale. 6 months
Secondary Fatigue Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale. 1 month
Secondary Fatigue Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale. 2 months
Secondary Fatigue Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale. 3 months
Secondary Fatigue Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale. 6 months
Secondary Anger Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale. 1 month
Secondary Anger Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale. 2 months
Secondary Anger Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale. 3 months
Secondary Anger Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale. 6 months
See also
  Status Clinical Trial Phase
Completed NCT05452499 - Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae N/A
Recruiting NCT05037682 - Pain and Opioid Management in Older Adults N/A
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Recruiting NCT05382962 - iCanCope With Post-Operative Pain (iCanCope PostOp) N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Active, not recruiting NCT04850079 - EHR Precision Drug Treatment in Neonates
Completed NCT03272139 - Interscalene Block Versus Superior Trunk Block Phase 4
Completed NCT03271151 - Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Phase 4
Completed NCT03886142 - Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis N/A
Recruiting NCT05761392 - APP-based Precise Management System of Chronic Intractable Pain N/A
Recruiting NCT05877157 - Pain AND Opioids After Surgery
Completed NCT03947749 - Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Recruiting NCT04874038 - Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) Phase 3
Completed NCT04280796 - Changes in Affective Pain Processing in Human Volunteers N/A
Withdrawn NCT05125978 - Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain Phase 2
Not yet recruiting NCT04328805 - Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome. Phase 4
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2
Completed NCT04089618 - Meditation Based Lifestyle Modification in Chronic Pain N/A
Recruiting NCT05699837 - Alpha Entrainment for Pain and Sleep (Extension) N/A